Control Group:Radiofrequency Ablation

4 trials

Sponsors

Chinese PLA General Hostital, The fifth medical center of PLA General Hospital, Shandong University, The First Affiliated Hospital of Nanjing Medical University

Conditions

Atrial FibrillationLiver cancerliver cancer

Phase 4

Radiofrequency ablation (RFA) combined with trepril monoclonal antibody (PD-1) in the treatment of recurrent HCC

Active, not recruitingChiCTR1900027807

The fifth medical center of PLA General HospitalLiver cancer

Start: 2020-01-01Updated: 2022-01-24

Unknown Phase

Independently developed high-voltage steep pulse therapeutic apparatus in the treatment of hepatoma: a randomized controlled trial

Active, not recruitingChiCTR1800017516

Chinese PLA General Hostitalliver cancer

Start: 2018-08-15Updated: 2020-09-21

Effects of radiofrequency ablation of atrial fibrillation plus left atrial appendage closure versus radiofrequency ablation alone on left ventricular function and structure: a randomized controlled study

Active, not recruitingChiCTR2100051862

Shandong UniversityAtrial Fibrillation

Start: 2021-10-04Updated: 2022-06-27

Comparison of Pulsed field vs. Radiofrequency Ablation on Early recurrence during atrial fibrillation blanking periods and patient clinical benefits: Redefining the blanking period

Active, not recruitingChiCTR2500103059

The First Affiliated Hospital of Nanjing Medical UniversityAtrial Fibrillation

Start: 2025-06-06Updated: 2025-05-26

Related Papers

Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study

Frontiers in Oncology2022-09-2911 citations